Survival benefit of neoadjuvant FOLFIRINOX for patients with borderline resectable pancreatic cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Survival benefit of neoadjuvant FOLFIRINOX for patients with borderline resectable pancreatic cancer

Published:2024-02-01 Issue:2 Volume:28 Page:229-237
ISSN:2508-5778
Container-title:Annals of Hepato-Biliary-Pancreatic Surgery
language:en
Short-container-title:Ann Hepatobiliary Pancreat Surg

Author:

Waugh Evelyn¹^ORCID,Glinka Juan¹^ORCID,Breadner Daniel²^ORCID,Liu Rachel¹^ORCID,Tang Ephraim¹^ORCID,Allen Laura¹^ORCID,Welch Stephen²^ORCID,Leslie Ken¹^ORCID,Skaro Anton¹^ORCID

Affiliation:

1. Division of General Surgery, Department of Surgery, Western University, London, ON, Canada

2. Division of Medical Oncology, Department of Oncology, Western University, London, ON, Canada

Publisher

The Korean Association of Hepato-Biliary-Pancreatic Surgery

Link

https://pdf.medrang.co.kr/kjhbps/2024/028/ahbps-28-2-229.pdf

Reference34 articles.

1. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes

2. Borderline resectable pancreatic cancer: Definitions and management

3. Neoadjuvant Treatment for Pancreatic Cancer

4. Neoadjuvant therapy for patients with borderline resectable pancreatic cancer: A systematic review and meta-analysis of response and resection percentages

5. Neoadjuvant Chemotherapy in Pancreatic Cancer: An Appraisal of the Current High-Level Evidence

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP